Christian Waage
Insider CIK 1553179 · WBSN VP, General Cousel · RCPT Senior VP & General Counsel · GOSS EVP, Tech Ops and Admin · HRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 2,900,026 | — | $0 | 2,900,026 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 2,900,026 | — | $0 | 2,900,026 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 70,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 126,667 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 157,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 157,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 125,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 375,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 440,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 506,250 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 47,667 | — | $0 | 47,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 126,667 | — | $0 | 126,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 157,500 | — | $0 | 157,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 157,500 | — | $0 | 157,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 125,000 | — | $0 | 125,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 375,000 | — | $0 | 375,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 440,000 | — | $0 | 440,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 506,250 | — | $0 | 506,250 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 60,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 47,667 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2026-01-30 | 2026-02-03 | 53,960 | — | $0 | 53,960 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 506,250 | — | $0 | 506,250 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2026-01-02 | 2026-01-05 | 84,500 | — | $0 | 814,061 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2025-10-01 | 2025-10-02 | 125,000 | — | $0 | 710,934 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2025-03-04 | 2025-03-06 | 440,000 | — | $0 | 440,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 35,900 | — | $0 | 35,900 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2025-01-31 | 2025-02-04 | 17,950 | — | $0 | 84,130 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-30 | 2025-02-03 | 35,900 | $1.73 | $62.1K | 35,900 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2025-01-30 | 2025-02-03 | 17,950 | — | $0 | 84,130 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2024-03-27 | 2024-03-28 | 6,430 | $1.16 | $7.5K | 585,934 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 83,685 | — | $0 | 83,685 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2024-01-19 | 2024-01-19 | 13,948 | — | $0 | 66,180 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 375,000 | — | $0 | 375,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 125,000 | — | $0 | 125,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 3,376 | $0.13 | $439 | 3,376 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2023-07-24 | 2023-07-26 | 13,504 | $1.82 | $24.6K | 45,892 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 126,667 | — | $0 | 126,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 47,667 | — | $0 | 47,667 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 105,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 190,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 90,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2023-05-05 | 2023-05-09 | 71,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-03-20 | 2023-03-22 | 157,500 | — | $0 | 157,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2023-03-20 | 2023-03-22 | 18,500 | $1.20 | $22.2K | 32,388 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2022-12-16 | 2022-12-20 | 77,160 | — | $0 | 77,160 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2022-12-16 | 2022-12-20 | 38,580 | — | $0 | 52,232 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2022-12-07 | 2022-12-09 | 157,500 | — | $0 | 157,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2022-07-15 | 2022-07-15 | 6,934 | $7.21 | $50.0K | 13,888 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2022-03-23 | 2022-03-24 | 10,722 | $8.92 | $95.6K | 579,008 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2022-01-06 | 2022-01-10 | 190,000 | — | $0 | 190,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2021-12-22 | 2021-12-23 | 20,903 | — | $0 | 20,903 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2021-12-22 | 2021-12-23 | 10,452 | — | $0 | 13,652 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-12-21 | 2021-12-23 | 300 | $9.73 | $2.9K | 3,200 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-09-21 | 2021-09-23 | 300 | $12.31 | $3.7K | 3,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-06-21 | 2021-06-22 | 300 | $15.20 | $4.6K | 3,800 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-04-15 | 2021-04-16 | 300 | $17.51 | $5.3K | 4,100 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2021-03-23 | 2021-03-25 | 5,490 | $9.48 | $52.0K | 588,199 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2021-02-25 | 2021-03-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2021-02-25 | 2021-03-01 | 45,000 | — | $0 | 593,689 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-12-21 | 2020-12-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2020-12-21 | 2020-12-23 | 3,000 | — | $0 | 4,400 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2020-10-14 | 2020-10-14 | 2,500 | $9.53 | $23.8K | 6,954 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-10-13 | 2020-10-15 | 437 | — | $0 | 437 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-04-15 | 2020-04-17 | 713 | — | $0 | 713 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 71,500 | — | $0 | 71,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2020-02-14 | 2020-02-19 | 46,500 | — | $0 | 547,998 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-12-19 | 2019-12-23 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2019-09-27 | 2019-09-27 | 1,000 | $16.65 | $16.6K | 4,454 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2019-05-15 | 2019-05-16 | 1,400 | $18.04 | $25.3K | 1,400 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2019-03-25 | 2019-03-26 | 105,000 | — | $0 | 105,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 15,543 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2019-02-12 | 2019-02-12 | 1,550 | $16.00 | $24.8K | 501,498 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 3,454 | — | $0 | 3,454 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2018-12-15 | 2018-12-18 | 17,000 | — | $0 | 17,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2017-12-18 | 2017-12-20 | 17,000 | — | $0 | 17,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2017-04-05 | 2017-04-07 | 1,125 | — | $0 | 1,125 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-12-21 | 2016-12-23 | 15,500 | — | $0 | 15,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-06-22 | 2016-06-23 | 1,500 | — | $0 | 1,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-06-22 | 2016-06-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 112,500 | $209.35 | $23.55M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 36,945 | $190.49 | $7.04M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 9,500 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | M Exercise deriv | 2015-05-01 | 2015-05-05 | 12,500 | — | $0 | 112,500 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2015-05-01 | 2015-05-05 | 12,500 | $154.46 | $1.93M | 0 | SEC↗ |
| RCPT Receptos, Inc. | M Exercise | 2015-05-01 | 2015-05-05 | 12,500 | $22.65 | $283.1K | 12,500 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-04-01 | 2015-04-03 | 9,500 | — | $0 | 9,500 | SEC↗ |
| RCPT Receptos, Inc. | M Exercise deriv | 2015-01-16 | 2015-01-20 | 25,000 | — | $0 | 125,000 | SEC↗ |
| RCPT Receptos, Inc. | M Exercise | 2014-09-16 | 2015-01-20 | 25,000 | $22.65 | $566.3K | 25,000 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-09-16 | 2015-01-20 | 25,000 | $107.05 | $2.68M | 0 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-04-03 | 2014-04-07 | 36,945 | — | $0 | 36,945 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-11-25 | 2013-11-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| WBSN WEBSENSE INC | D To issuer deriv | 2013-06-25 | 2013-06-27 | 21,000 | $10.14 | $212.9K | 0 | SEC↗ |
| WBSN WEBSENSE INC | D To issuer deriv | 2013-06-25 | 2013-06-27 | 75,000 | $9.74 | $730.5K | 0 | SEC↗ |
| WBSN WEBSENSE INC | D To issuer | 2013-06-25 | 2013-06-27 | 5,250 | — | $0 | 0 | SEC↗ |
| WBSN WEBSENSE INC | D To issuer | 2013-06-25 | 2013-06-27 | 3,887 | — | $0 | 0 | SEC↗ |
| WBSN WEBSENSE INC | A Award | 2013-06-25 | 2013-06-27 | 5,250 | — | $0 | 5,250 | SEC↗ |
| WBSN WEBSENSE INC | M Exercise deriv | 2013-02-10 | 2013-02-12 | 21,000 | — | $0 | 21,000 | SEC↗ |
| WBSN WEBSENSE INC | A Award | 2013-02-10 | 2013-02-12 | 3,500 | $0.01 | $35 | 3,500 | SEC↗ |
| WBSN WEBSENSE INC | M Exercise deriv | 2012-07-31 | 2012-07-31 | 75,000 | — | $0 | 75,000 | SEC↗ |